In a research note sent out to clients and investors on Monday, the equity research analysts from Canaccord Genuity Group raised their price objective for HIVE Blockchain Technologies (NASDAQ: HIVE) from $5.50 to $7.00. The note was about the company’s stock. The company advises potential purchasers in question to “buy” the stock. Canaccord Genuity Group has projected a price target for the supply, and based on where it is trading right now; they estimate that it has a potential upside of 47.06% from here. Several other equity research analysts have recently published reports on HIVE, which can be found on their respective websites. According to a research report issued on Monday, Canaccord Genuity Group increased its price target for HIVE Blockchain Technologies from $5.50 to $7.00. The report’s subject matter was the company. In a research report published on Thursday, August 18, HC Wainwright maintained their “buy” rating on the shares of HIVE Blockchain Technologies and increased their price target for the company in a report that was made public. On Monday, the price at which trading on the NASDAQ HIVE got underway was $4.76. The current price-to-earnings ratio for the stock is 95.20, which is why it has a market value of $391.51 million.
The current price of HIVE Blockchain Technologies is $28.00, the company’s all-time high, and the current price of $2.82 is the company’s all-time low. 0.11, 3.11, and 3.11 are the exact values for all three ratios, including the current, quick, and debt-to-equity ratios. The company’s moving average over the previous 200 days is $6.42, and the moving average for the last fifty days is $4.37. On July 20, the most recent quarterly report for HIVE Blockchain Technologies (NASDAQ: HIVE) was published and made available for the general public to review. HIVE Blockchain Technologies’ return on equity was a negative 0.25%, and the company’s net margin was 0.57%. $49.78 million was recorded as the company’s total revenue during the period in question. Equity research professionals anticipate that HIVE Blockchain Technologies’ earnings per share for the current fiscal year will be -1.24. An institutional investor purchased HIVE Blockchain Technologies shares in one of the company’s most recent transactions. In the most recent Form 13F that the company has filed with the Securities and Exchange Commission, it was revealed that during the second quarter of 2018, State Street Corporation increased its shares of HIVE Blockchain Technologies Ltd. (NASDAQ: HIVE).
The fund shelled out close to one million dollars and thirty-six thousand seven hundred and thirty-one dollars to purchase 336,731 shares of the corporation’s stock. At the end of the most recent fiscal quarter, State Street Corporation held a stake in HIVE Blockchain Technologies, equal to approximately 0.41 percent of the company. To the tune of 8.08% of the company’s shares, hedge funds and other types of institutional investors are the owners of those shares. HIVE Blockchain Technologies Ltd., which operates in Canada, Iceland, and Sweden, is the company responsible for mining bitcoins. HIVE Blockchain Technologies Ltd. One of its primary focuses is the mining and trading various forms of digital currency, including Bitcoin, Ethereum, and Ethereum Classic, among others. The company formerly known as Leeta Gold Corp. changed its name to HIVE Blockchain Technologies Ltd.
